Duration of viral clearance and factors associated with viral clearance among COVID-19 patients admitted in a tertiary care center in north Kerala


  • Jerrin Maria Jose Department of Community Medicine, Government Medical College, Kannur, Kerala, India
  • Jayasree Anandabhavan Kumaran Department of Community Medicine, Government Medical College, Kannur, Kerala, India




COVID-19, RTPCR conversion time, Viral clearance


Background: COVID-19 pandemic has afflicted the global health scenario for nearly two years. There are limited studies regarding potential predictors of viral clearance in COVID-19 patients. These predictors can aid in identifying patients with prolonged viral shedding and initiate further research for interpreting host immune response to COVID-19. Viral clearance data in treated patients may shed light on the relationship between the host immune system and SARS-CoV-2. Objective of this study was to estimate viral clearance and study the factors associated with viral clearance in COVID-19 patients.

Methods: A descriptive study was conducted among 588 COVID-19 patients admitted during the 6-month study period. Data was collected from case records and analyzed using SPSS version 21. Results expressed as mean, standard deviation, frequencies, and percentages. Pearson Chi square test used to find association between viral clearance and associated factors.

Results: Among the 588 COVID-19 patients, majority (54%) were females. 21-30 years age-group had the maximum proportion (29.2%) of cases. Most common comorbidity reported was diabetes mellitus. The mean duration of viral clearance (VC) was 8.16±2.1 days. Delayed viral clearance was present in 21% of the study population. There was statistically significant association between male gender and delayed viral clearance. ICU admission and delayed VC also had significant association, with 95% of those admitted in ICU having delayed VC. Male gender could be a confounding variable for association between ICU admission and delayed viral clearance.

Conclusions: One fifth of the study population had delayed viral clearance. Delayed viral clearance is associated with male gender and ICU admission.


WHO Coronavirus (COVID-19) Dashboard. Available from: https://covid19.who.int. Accessed on 1 December 2021.

Ministry of Health and Family Welfare COVID-19. New Delhi. Available from: https://www.mohfw.gov.in. Accessed on 1 December 2021.

Rabaan AA, Al-Ahmed SH, Haque S, Sah R, Tiwari R, Malik YS, et al. SARS-CoV-2, SARS-CoV, and MERS-COV: a comparative overview. Infez Med. 2020;28(2):174-84.

Bohn MK, Hall A, Sepiashvili L, Jung B, Steele S, Adeli K. Pathophysiology of COVID-19: mechanisms underlying disease severity and progression. Physiology. 2020;35(5):288-301.

Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497-506.

Bohn MK, Lippi G, Horvath A, Sethi S, Koch D, Ferrari M, et al. Molecular, serological, and biochemical diagnosis and monitoring of COVID-19: IFCC taskforce evaluation of the latest evidence. Clin Chem Lab Med. 2020;58(7):1037-52.

Saurabh S, Kumar R, Gupta MK, Bhardwaj P, Nag VL, Garg MK, et al. Prolonged persistence of SARS-CoV-2 in the upper respiratory tract of asymptomatic infected individuals. QJM Mon J Assoc Phys. 2020;113(8):556-60.

Park SY, Yun SG, Shin JW, Lee BY, Son HJ, Lee S, et al. Persistent severe acute respiratory syndrome coronavirus 2 detection after resolution of coronavirus disease 2019-associated symptoms/ signs. Korean J Intern Med. 2020;35(4):793-6.

Deng W, Guang TW, Yang M, Li JR, Jiang DP, Li CY, et al. Positive results for patients with COVID-19 discharged form hospital in Chongqing, China. BMC Infect Dis. 2020;20(1):429.

Farina N, Ramirez GA, De Lorenzo R, Di Filippo L, Conte C, Ciceri F, et al. COVID-19: Pharmacology and kinetics of viral clearance. Pharmacol Res. 2020;161:105114.

Huang X, Wei F, Hu L, Wen L, Chen K. Epidemiology and clinical characteristics of COVID-19. Arch Iran Med. 2020;23(4):268-71

Abate BB, Kassie AM, Kassaw MW, Aragie TG, Masresha SA. Sex difference in coronavirus disease (COVID-19): a systematic review and meta-analysis. BMJ open. 2020;10(10):e040129.

Mohan A, Tiwari P, Bhatnagar S, Patel A, Maurya A, Dar L, et al. Clinico-demographic profile and hospital outcomes of COVID-19 patients admitted at a tertiary care centre in north India. Indian J Med Res. 2020;152(1 and 2):61-9.

Aggarwal A, Shrivastava A, Kumar A, Ali A. clinical and epidemiological features of SARS-CoV-2 patients in SARI ward of a tertiary care centre in New Delhi. J Assoc Physicians India. 2020;68(7):19-26.

Kayina CA, Haritha D, Soni L, Behera S, Nair PR, Gouri M, et al. Epidemiological and clinical characteristics and early outcome of COVID-19 patients in a tertiary care teaching hospital in India: a preliminary analysis. Indian J Med Res. 2020;152(1 and 2):100–4.

Grasselli G, Greco M, Zanella A, Albano G, Antonelli M, Bellani G, et al. Risk factors associated with mortality among patients with COVID-19 in intensive care units in Lombardy, Italy. JAMA Intern Med. 2020;180(10):1345-55.

Wei CJ, Hu XX, Ye GM, Yang JM, Cheng ZS, Wang XH. Time and risk factors of viral clearance in COVID-19 patients. Chin Med J. 2021;134(17):2131-3.

Ling Y, Xu SB, Lin YX, Tian D, Zhu ZQ, Dai FH, et al. Persistence and clearance of viral RNA in 2019 novel coronavirus disease rehabilitation patients. Chin Med J. 2020;133(9):1039-43.

Wang K, Zhang X, Sun J, Ye J, Wang F, Hua J, et al. Differences of severe acute respiratory syndrome coronavirus 2 shedding duration in sputum and nasopharyngeal swab specimens among adult inpatients with coronavirus disease 2019. Chest. 2020;158(5):1876-84.

Yuan J, Zou R, Zeng L, Kou S, Lan J, Li X, et al. The correlation between viral clearance and biochemical outcomes of 94 COVID-19 infected discharged patients. Inflamm Res. 2020;69(6):599-606.

Wang L, Gao YH, Lou LL, Zhang GJ. The clinical dynamics of 18 cases of COVID-19 outside of Wuhan, China. Eur Respir J. 2020;55(4):2000398.

Ikegami S, Benirschke R, Flanagan T, Tanna N, Klein T, Elue R, et al. Persistence of SARS-CoV-2 nasopharyngeal swab PCR positivity in COVID-19 convalescent plasma donors. Transfusion. 2020;60(12):2962-8.

Xu K, Chen Y, Yuan J, Yi P, Ding C, Wu W, et al. Factors associated with prolonged viral rna shedding in patients with coronavirus disease 2019 (COVID-19). Clin Infect Dis. 2020;71(15):799-806.

Shi D, Wu W, Wang Q, Xu K, Xie J, Wu J, et al. Clinical characteristics and factors associated with long-term viral excretion in patients with severe acute respiratory syndrome coronavirus 2 infection: a single-center 28-day study. J Infect Dis. 2020;222(6):910-8.

Rhee C, Kanjilal S, Baker M, Klompas M. Duration of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infectivity: when is it safe to discontinue isolation? Clin Infect Dis. 2021;72(8):1467-74.

Lu J, Peng J, Xiong Q, Liu Z, Lin H, Tan X, et al. Clinical, immunological and virological characterization of COVID-19 patients that test re-positive for SARS-CoV-2 by RT-PCR. EBioMedicine. 2020 Sep 1;59:102960.

Fontana LM, Villamagna AH, Sikka MK, McGregor JC. Understanding viral shedding of severe acute respiratory coronavirus virus 2 (SARS-CoV-2): Review of current literature. Infect Control Hosp Epidemiol. 2021;42(6):659-68.




How to Cite

Jose, J. M., & Kumaran, J. A. (2022). Duration of viral clearance and factors associated with viral clearance among COVID-19 patients admitted in a tertiary care center in north Kerala. International Journal Of Community Medicine And Public Health, 9(4), 1709–1714. https://doi.org/10.18203/2394-6040.ijcmph20220842



Original Research Articles